Measured-Calculated Dose Agreement:
Prostate:
91.4%
±
4.1%
(25 patients, 175 beams)
(3%/2mm)
Spine SBRT:
77.1%
±
9.7%
(25 patients, 214 beams)
(3%/2mm)
Patient-Specific QC
MapCheck
Why the Difference in Agreement?
Same Accelerator.
Same Measurement Device.
Beam Model?




